中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
A Proteomic Study on Cell Cycle Progression of Endothelium Exposed to Tumor Conditioned Medium and the Possible Role of Cyclin D-1/E

文献类型:会议论文

作者Li AL; Li HW; Jin G(靳刚); Xiu RJ
出版日期2003-02-20
会议名称5th Asian Congress for Microcirculation, FEB 20-22, 2003 MANILA, PHILIPPINES
通讯作者靳刚
中文摘要This study was designed to comprehensively analyze the differential expression of proteins from human umbilical vein endothelial cells (HUVECs) exposed to tumor conditioned medium (TCM) and to identify the key regulator in the cell cycle progression. The HUVECs were exposed to TCM from breast carcinoma cell line MDA-MB-231, then their cell cycle distribution was measured by flow cytometer (FCM). The role of protein in cell cycle progression was detected via two-dimensional polyacrylamide gel electrophoresis (2-DE) and western blotting. Following the stimulation of TCM, HUVECs showed a more cells in the S phase than did the negative control group (ECGF-free medium with 20% FBS), but the HUVECs' level was similar to the positive control group (medium with 25 mug/ml ECGF and 20% FBS). Increased expression of cyclin D-1/E and some changes in other related proteins occurred after incubation with TCM. From our results, we can conclude that breast carcinoma cell line MDA-MB-231 may secrete soluble pro-angiogenic factors that induce the HUVEC angiogenic switch, during which the expression of cell cycle regulator cyclin D-1/E increases and related proteins play an important role in this process.
收录类别CPCI-S
会议录CLINICAL HEMORHEOLOGY AND MICROCIRCULATION,2003,29(3-4):383-390
学科主题力学
语种英语
WOS记录号WOS:000188240800032
源URL[http://dspace.imech.ac.cn/handle/311007/13746]  
专题力学研究所_力学所知识产出(1956-2008)
推荐引用方式
GB/T 7714
Li AL,Li HW,Jin G,et al. A Proteomic Study on Cell Cycle Progression of Endothelium Exposed to Tumor Conditioned Medium and the Possible Role of Cyclin D-1/E[C]. 见:5th Asian Congress for Microcirculation, FEB 20-22, 2003 MANILA, PHILIPPINES.

入库方式: OAI收割

来源:力学研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。